PRECIGEN Investors


European Society of Gene & Cell Therapy (ESGTC) 30th Annual Congress

Oct 24, 2023 at 5:00 PM - 7:00 PM CEST

Dr. Scott M. Norberg, Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, presented an abstract titled, "Significant clinical benefit and enhanced T-cell responses with repeated administration of PRGN-2012, a novel gorilla adenoviral vector based immunotherapy, in adult patients with severe Recurrent Respiratory Papillomatosis.


Brussels, Belgium